Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06922760 · ClinicalTrials.gov registry record
Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 233
- Enrollment target
NCT06922760 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 233 participants.
The verdict
NCT06922760 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 233 participants
- Enrollment target
Study Summary
This study will utilize University of Michigan EMR data to form a retrospective cohort of severe asthma patients on biologic therapies for asthma with computed tomography (CT) imaging and known outcomes on therapy. These images will then be analyzed using morphomics, a combination of high-throughput image analysis and deep learning techniques, to derive imaging biomarkers that will be able to predict therapeutic response to biologics. These biomarkers will then be tested in a second cohort from the National Jewish Health to assess for validity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2024-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06922760
The ClinicalTrials.gov registry entry for NCT06922760 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06922760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06922760 about?
NCT06922760 is a clinical study titled "Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts". This study will utilize University of Michigan EMR data to form a retrospective cohort of severe asthma patients on biologic therapies for asthma with computed tomography (CT) imaging and known outcomes on therapy. These images will then be analyzed using morphomics, a combination of high-throughput...
What is the current status of trial NCT06922760?
This trial is currently completed. The enrollment target is 233 participants. The study started on 2021-01-15. Estimated completion is 2024-07-31.
Who is sponsoring clinical trial NCT06922760?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.